WEBSITE BSE:544282 NSE: SAGILITY Inc. Year: 2021 Industry: Business Support My Bucket: Add Stock
Last updated: 15:59
Sagility India Limited is a healthcare-focused business process outsourcing (BPO) company that provides innovative solutions to streamline healthcare operations and improve patient outcomes. With expertise in healthcare administration, Sagility offers services across multiple domains, including claims processing, patient engagement, and provider data management. The company leverages advanced analytics, automation, and artificial intelligence to optimize healthcare processes, ensuring efficiency and accuracy. Sagility aims to address the compl...Read More
Sagility India Limited is a healthcare-focused business process outsourcing (BPO) company that provides innovative solutions to streamline healthcare operations and improve patient outcomes. With expertise in healthcare administration, Sagility offers services across multiple domains, including claims processing, patient engagement, and provider data management. The company leverages advanced analytics, automation, and artificial intelligence to optimize healthcare processes, ensuring efficiency and accuracy. Sagility aims to address the complex challenges of the healthcare industry by delivering scalable solutions that enhance service quality while reducing operational costs. Its team of professionals is dedicated to supporting healthcare payers and providers, working to enhance patient experiences and optimize the flow of healthcare information. Known for its commitment to compliance and data security, Sagility is a trusted partner for clients seeking to transform their healthcare delivery models. Through continuous innovation, Sagility India Limited is shaping the future of healthcare services with a customer-centric approach. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹20097 Cr.
Stock P/E 37.3
P/B 2.2
Current Price ₹42.9
Book Value ₹ 19.6
Face Value 10
52W High ₹57.9
Dividend Yield 0%
52W Low ₹ 35.8
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1094 | 1260 | 1283 | 1223 | 1325 | 1453 | 1568 | 1539 | 1658 | 1971 |
| Other Income | 29 | 6 | 5 | 24 | 15 | 44 | 10 | 10 | 58 | 8 |
| Total Income | 1123 | 1266 | 1288 | 1248 | 1340 | 1497 | 1579 | 1549 | 1717 | 1980 |
| Total Expenditure | 860 | 1000 | 976 | 1029 | 1024 | 1061 | 1195 | 1193 | 1243 | 1460 |
| Operating Profit | 263 | 266 | 312 | 218 | 316 | 436 | 383 | 356 | 473 | 520 |
| Interest | 48 | 47 | 43 | 37 | 30 | 30 | 30 | 27 | 25 | 25 |
| Depreciation | 171 | 176 | 176 | 110 | 126 | 116 | 114 | 118 | 122 | 124 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -33 |
| Profit Before Tax | 43 | 44 | 93 | 71 | 160 | 290 | 239 | 210 | 327 | 339 |
| Provision for Tax | 8 | -27 | 13 | 49 | 43 | 73 | 56 | 62 | 76 | 71 |
| Profit After Tax | 35 | 71 | 80 | 22 | 117 | 217 | 183 | 149 | 251 | 268 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 35 | 71 | 80 | 22 | 117 | 217 | 183 | 149 | 251 | 268 |
| Adjusted Earnings Per Share | 0.2 | 0.4 | 0.2 | 0 | 0.3 | 0.5 | 0.4 | 0.3 | 0.5 | 0.6 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|
| Net Sales | 923 | 4218 | 4754 | 5570 | 6736 |
| Other Income | 21 | 18 | 31 | 56 | 86 |
| Total Income | 944 | 4236 | 4784 | 5626 | 6825 |
| Total Expenditure | 734 | 3191 | 3668 | 4272 | 5091 |
| Operating Profit | 211 | 1045 | 1116 | 1354 | 1732 |
| Interest | 65 | 215 | 185 | 127 | 107 |
| Depreciation | 147 | 644 | 689 | 467 | 478 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | -33 |
| Profit Before Tax | -2 | 186 | 242 | 760 | 1115 |
| Provision for Tax | 3 | 42 | 13 | 221 | 265 |
| Profit After Tax | -5 | 144 | 228 | 539 | 851 |
| Adjustments | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | -5 | 144 | 228 | 539 | 851 |
| Adjusted Earnings Per Share | -0 | 0.7 | 0.5 | 1.2 | 1.8 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 17% | 82% | 0% | 0% |
| Operating Profit CAGR | 21% | 86% | 0% | 0% |
| PAT CAGR | 136% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -1% | NA% | NA% | NA% |
| ROE Average | 7% | 5% | 4% | 4% |
| ROCE Average | 10% | 7% | 5% | 5% |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Shareholder's Funds | 4027 | 6207 | 6443 | 8336 |
| Minority's Interest | 0 | 0 | 0 | 0 |
| Borrowings | 4184 | 2324 | 1665 | 567 |
| Other Non-Current Liabilities | 989 | 942 | 969 | 925 |
| Total Current Liabilities | 885 | 1056 | 1452 | 1089 |
| Total Liabilities | 10085 | 10529 | 10529 | 10917 |
| Fixed Assets | 8621 | 8607 | 8667 | 8997 |
| Other Non-Current Assets | 58 | 129 | 142 | 99 |
| Total Current Assets | 1406 | 1793 | 1720 | 1821 |
| Total Assets | 10085 | 10529 | 10529 | 10917 |
| #(Fig in Cr.) | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 0 | 374 | 585 | 344 |
| Cash Flow from Operating Activities | -32 | 857 | 973 | 1214 |
| Cash Flow from Investing Activities | -7714 | -129 | -469 | -964 |
| Cash Flow from Financing Activities | 8116 | -545 | -751 | -256 |
| Net Cash Inflow / Outflow | 370 | 183 | -247 | -6 |
| Closing Cash & Cash Equivalent | 374 | 585 | 344 | 344 |
| # | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|
| Earnings Per Share (Rs) | -0.02 | 0.75 | 0.53 | 1.15 |
| CEPS(Rs) | 0.74 | 4.11 | 2.14 | 2.15 |
| DPS(Rs) | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | -13.92 | -2.56 | 15.04 | 17.54 |
| Core EBITDA Margin(%) | 20.53 | 24.35 | 22.83 | 23.3 |
| EBIT Margin(%) | 6.86 | 9.49 | 8.98 | 15.93 |
| Pre Tax Margin(%) | -0.2 | 4.4 | 5.08 | 13.65 |
| PAT Margin (%) | -0.51 | 3.4 | 4.8 | 9.68 |
| Cash Profit Margin (%) | 15.44 | 18.68 | 19.3 | 18.06 |
| ROA(%) | -0.05 | 1.39 | 2.17 | 5.03 |
| ROE(%) | 0 | 0 | 7.67 | 7.36 |
| ROCE(%) | 0.77 | 4.78 | 5.06 | 10.14 |
| Receivable days | 366.1 | 86.3 | 86.38 | 80.21 |
| Inventory Days | 0 | 0 | 0 | 0 |
| Payable days | 0 | 0 | 0 | 0 |
| PER(x) | 0 | 0 | 0 | 37.29 |
| Price/Book(x) | 0 | 0 | 0 | 2.45 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 6.2 | 0.87 | 1.23 | 3.69 |
| EV/Core EBITDA(x) | 27.21 | 3.5 | 5.25 | 15.19 |
| Net Sales Growth(%) | 0 | 356.83 | 12.69 | 17.17 |
| EBIT Growth(%) | 0 | 532.12 | 6.57 | 107.89 |
| PAT Growth(%) | 0 | 3173.69 | 58.99 | 136.18 |
| EPS Growth(%) | 0 | 3179.42 | -28.81 | 116.29 |
| Debt/Equity(x) | -1.57 | -4.73 | 0.3 | 0.1 |
| Current Ratio(x) | 1.59 | 1.7 | 1.18 | 1.67 |
| Quick Ratio(x) | 1.59 | 1.7 | 1.18 | 1.67 |
| Interest Cover(x) | 0.97 | 1.86 | 2.31 | 6.98 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0.04 |
| # | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoter | 82.39 | 82.39 | 67.38 | 67.38 | 50.95 |
| FII | 3.78 | 3.39 | 5.99 | 5.59 | 10.25 |
| DII | 7.25 | 7.48 | 14.06 | 14.88 | 21.36 |
| Public | 6.58 | 6.74 | 12.58 | 12.15 | 17.44 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoter | 385.71 | 385.71 | 315.41 | 315.41 | 238.51 |
| FII | 17.67 | 15.87 | 28.02 | 26.19 | 47.98 |
| DII | 33.92 | 35 | 65.83 | 69.64 | 100 |
| Public | 30.82 | 31.55 | 58.88 | 56.89 | 81.64 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Total | 468.13 | 468.13 | 468.13 | 468.13 | 468.13 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
